Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Usana Health Sciences Inc.
NEW YORK, July 24. 2013 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Usana Health Sciences Inc. ("Usana" or the "Company") (NYSE: USNA). The investigation focuses on whether the Company and its executives violated federal securities laws.
On July 24, 2013, shares of Usana fell $6.56 or 8.14% to close at $73.99 after the company announced in a regulatory filing released after market close on July 23, 2013 that the Securities and Exchange Commission ("SEC") is conducting an investigation, which appears to involve possible issues regarding trading in the Company's stock during late 2012 by certain of the Company's directors, including the Chairman. The Company, and members of its Board of Directors, are fully cooperating with the SEC in connection with this matter.
If you are aware of any facts relating to this investigation, or purchased shares of Usana you can assist this investigation by contacting either Peretz Bronstein or his Investor Relations Coordinator Eitan Kimelman of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email email@example.com. Those who inquire by e-mail are encouraged to include their mailing address and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Eitan Kimelman 212-697-6484
SOURCE Bronstein, Gewirtz & Grossman, LLC
More by this Source
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Akorn, Inc.
Mar 03, 2014, 16:52 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.